Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

NCT07238972 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Anemia
Iron Deficiencies
Iron Deficiency Anemia
Cardiac Surgery
Heart Valve Diseases

Interventions

DRUG: Ferric derisomaltose
DRUG: Placebo (0.9% saline)

Sponsor

Yonsei University